Igf 1 Signaling Pathway In Neurodegeneration represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications.
The Insulin-like Growth Factor 1 (IGF-1) signaling pathway is a critical regulator of neuronal survival, growth, metabolism, and synaptic plasticity. IGF-1 is a peptide hormone that plays essential roles in brain development, adult neurogenesis, and protection against neurodegenerative processes. The pathway signals through the IGF-1 receptor (IGF1R), activating multiple downstream cascades including PI3K/Akt, MAPK/ERK, and PLCγ, ultimately influencing gene expression, protein synthesis, mitochondrial function, and cellular resilience [1].
flowchart TD
A[IGF-1] --> B[IGF1R Tyrosine Kinase]
B --> C[IRS-1/2 Adapter Proteins]
C --> D1[PI3K/Akt Pathway]
C --> D2[Ras/Raf/MEK/ERK Pathway]
C --> D3[PLCγ Pathway]
D1 --> E1[mTORC1 Activation]
D1 --> E2[GSK3β Inhibition]
D1 --> E3[FOXO Transcription Factors]
D1 --> E4[Bad Phosphorylation]
D1 --> E5[PGC-1α Activation]
D2 --> F1[Elk-1 Activation]
D2 --> F2[c-Myc Expression]
D2 --> F3[Cell Growth Genes]
D3 --> G1[PKC Activation]
G1 --> G2[Calcium Signaling]
E1 --> H1[Protein Synthesis]
E1 --> H2[Autophagy Inhibition]
E2 --> H3[Tau Phosphorylation Reduction]
E3 --> H4[Pro-survival Genes]
E4 --> H5[Mitochondrial Apoptosis Prevention]
E5 --> H6[Mitochondrial Biogenesis]
F1 --> I1[Synaptic Plasticity Genes]
F2 --> I2[Cell Cycle Progression]
F3 --> I3[Neurite Outgrowth]
H1 --> J[Neuronal Survival & Function]
H2 --> J
H3 --> J
H4 --> J
H5 --> J
H6 --> J
I1 --> J
I2 --> J
I3 --> J
J --> K1[Neuroprotection]
J --> K2[Synaptic Maintenance]
J --> K3[Metabolic Support]
J --> K4[Adult Neurogenesis]
| Component |
Type |
Function in Neurodegeneration |
| IGF-1 |
Growth Factor |
Neuroprotective, promotes neuronal survival |
| IGF1R |
Receptor Tyrosine Kinase |
Highly expressed in brain, mediates IGF-1 effects |
| IRS-1/2 |
Adapter Protein |
Links IGF1R to PI3K, impaired in AD |
| PI3K |
Lipid Kinase |
Generates PIP3, activates Akt |
| Akt/PKB |
Ser/Thr Kinase |
Central mediator of cell survival |
| mTORC1 |
Kinase Complex |
Protein synthesis, autophagy regulation |
| GSK3β |
Kinase |
Tau phosphorylation, hyperactive in AD |
| FOXO |
Transcription Factor |
Pro-apoptotic when active, inhibited by Akt |
| PGC-1α |
Co-activator |
Mitochondrial biogenesis regulator |
| Ras/Raf/MEK/ERK |
Kinase Cascade |
Cell growth, synaptic plasticity |
In Alzheimer's disease, IGF-1 signaling exhibits a complex, often paradoxical role. While acute IGF-1 signaling is neuroprotective, chronic dysregulation contributes to pathology [2]:
- Brain IGF-1 resistance: AD brains show reduced IGF1R signaling despite normal or elevated IGF-1 levels, suggesting receptor desensitization
- IRS-1 dysfunction: Aβ oligomers bind to IRS-1, causing serine phosphorylation and pathway inhibition
- mTOR hyperactivation: Chronic Akt activation leads to mTORC1 overactivity, impairing autophagy and contributing to Aβ/tau accumulation
- SynapticIGF-1 signaling: Impaired IGF-1 signaling at synapses contributes to synaptic loss and cognitive decline
- Microglial effects: IGF-1 modulates microglial activation, with impaired signaling promoting pro-inflammatory phenotypes
IGF-1 signaling provides critical protection to dopaminergic neurons [3]:
- Dopaminergic neuron survival: IGF-1 promotes viability of substantia nigra pars compacta neurons
- α-synuclein interaction: IGF-1 can reduce α-synuclein aggregation through enhanced autophagy
- Mitochondrial function: PGC-1α activation through IGF-1/Akt promotes mitochondrial biogenesis, counteracting Complex I deficiency
- Neuroinflammation: IGF-1 has anti-inflammatory effects on microglia, potentially reducing dopaminergic neuron loss
¶ ALS and Motor Neuron Disease
IGF-1 has been extensively studied in ALS [4]:
- Motor neuron protection: IGF-1 promotes motor neuron survival and axonal integrity
- Synaptic maintenance: Critical for neuromuscular junction stability
- Therapeutic approaches: Intrathecal IGF-1 delivery has been explored in clinical trials
- Genetic links: ALS-associated mutations can affect IGF-1 signaling components
- BDNF interaction: IGF-1 signaling enhances BDNF expression and trafficking
- Metabolic support: Improves neuronal energy metabolism
- Mutant huntingtin effects: mHTT can impair IGF-1 signaling through multiple mechanisms
¶ Agonists and Analogues
| Agent |
Mechanism |
Status |
| Recombinant IGF-1 |
Direct IGF1R activation |
Clinical trials for ALS, AD |
| IGF-1 mimetics |
Bypass receptor activation |
Preclinical development |
| Peptide agonists |
Targeted IGF1R activation |
Preclinical |
| Agent |
Mechanism |
Status |
| Akt activators |
Downstream pathway activation |
Research phase |
| PI3K modulators |
Pathway enhancement |
Research phase |
- Exercise: Increases peripheral and brain IGF-1 levels
- Caloric restriction: Modulates IGF-1 signaling (reduces, then improves sensitivity)
- Growth hormone: Increases IGF-1 production
flowchart LR
subgraph IGF1
A[IGF-1 Signaling]
end
subgraph PI3K
B[PI3K/Akt Pathway]
end
subgraph MTOR
C[mTOR Pathway]
end
subgraph AUTOPH
D[Autophagy]
end
subgraph MITO
E[Mitochondrial Function]
end
subgraph INFLAM
F[Neuroinflammation]
end
A --> B
B --> C
B --> E
C -->|Inhibits| D
B -->|Activates| D
E --> F
F -->|Feedback| A
- PI3K/Akt pathway: Central downstream mediator of IGF-1 effects
- mTOR interaction: Bidirectional - IGF-1 activates mTOR, but mTOR can also affect IGF-1 signaling
- Autophagy: IGF-1/mTOR inhibits autophagy; pathway modulation can restore proteostasis
- Synaptic plasticity: Cross-talk with neurotrophic signaling (BDNF, NGF)
- Metabolism: Insulin/IGF-1 signaling is key metabolic regulator in brain
| Biomarker |
Sample |
Relevance |
| IGF-1 levels |
Serum, CSF |
Peripheral marker of GH-IGF axis |
| p-IRS-1 (Ser) |
Brain tissue |
Pathway inhibition marker |
| p-Akt levels |
Brain tissue, CSF |
Pathway activity |
| p-FOXO |
Brain tissue |
Transcription factor activation |
| IGF1R expression |
Brain tissue |
Receptor availability |
The study of Igf 1 Signaling Pathway In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- IGF-1 signaling and the brain: Crosstalk with neurological disorders
- Insulin resistance in Alzheimer's disease: Role of IGF-1 signaling
- IGF-1 and neuroprotection in Parkinson's disease
- IGF-1 therapy in ALS: From models to clinical trials
- Brain insulin resistance and cognitive decline in Alzheimer's disease
- Role of the IGF-1 signaling pathway in neuroinflammation
- mTOR and IGF-1 signaling in brain aging and neurodegeneration
- IGF-1, autophagy and neurodegenerative disease
- PGC-1α and mitochondrial biogenesis in neurodegeneration
- Therapeutic modulation of IGF-1 signaling in Alzheimer's disease
🔴 Low Confidence
| Dimension |
Score |
| Supporting Studies |
10 references |
| Replication |
0% |
| Effect Sizes |
25% |
| Contradicting Evidence |
0% |
| Mechanistic Completeness |
50% |
Overall Confidence: 31%